No retraction, correction or concern found when last checked on Oct 21, 2026.

Cellular uptake and in vivo distribution of mesenchymal-stem-cell-derived extracellular vesicles are protein corona dependent

Revadee Liam-Or, Farid N. Faruqu, Adam Walters and 9 more (opens in a new tab)

Nature Nanotechnology · 2024 · CC BY

doi:10.1038/s41565-023-01585-y (opens in a new tab)

Abstract

Extracellular vesicles (EVs) derived from mesenchymal stem cells are promising nanotherapeutics in liver diseases due to their regenerative and immunomodulatory properties. Nevertheless, a concern has been raised regarding the rapid clearance of exogenous EVs by phagocytic cells. Here we explore the impact of protein corona on EVs derived from two culturing conditions in which specific proteins acquired from media were simultaneously adsorbed on the EV surface. Additionally, by incubating EVs with serum, simulating protein corona formation upon systemic delivery, further resolved protein corona–EV complex patterns were investigated. Our findings reveal the potential influences of corona composition on EVs under in vitro conditions and their in vivo kinetics. Our data suggest that bound albumin creates an EV signature that can retarget EVs from hepatic macrophages. This results in markedly improved cellular uptake by hepatocytes, liver sinusoidal endothelial cells and hepatic stellate cells. This phenomenon can be applied as a camouflage strategy by precoating EVs with albumin to fabricate the albumin-enriched protein corona–EV complex, enhancing non-phagocytic uptake in the liver. This work addresses a critical challenge facing intravenously administered EVs for liver therapy by tailoring the protein corona–EV complex for liver cell targeting and immune evasion.

References 65

1.
Asrani SK, et al. Burden of liver diseases in the world. J. Hepatol. 2019;70:151-171.
Not in our library10.1016/j.jhep.2018.09.014 (opens in a new tab)
2.
Kwak KA, et al. Current perspectives regarding stem cell-based therapy for liver cirrhosis. Can. J. Gastroenterol. Hepatol. 2018;2018:4197857.
Not in our library10.1155/2018/4197857 (opens in a new tab)
3.
Guo Y, et al. Current status and future prospects of mesenchymal stem cell therapy for liver fibrosis. J. Zhejiang Univ. Sci. B. 2016;17:831-841.
Not in our library10.1631/jzus.b1600101 (opens in a new tab)
4.
Zagoura DS, et al. Therapeutic potential of a distinct population of human amniotic fluid mesenchymal stem cells and their secreted molecules in mice with acute hepatic failure. Gut. 2012;61:894-906.
Not in our library10.1136/gutjnl-2011-300908 (opens in a new tab)
5.
Li T, et al. Exosomes derived from human umbilical cord mesenchymal stem cells alleviate liver fibrosis. Stem Cells Dev. 2013;22:845-854.
Not in our library10.1089/scd.2012.0395 (opens in a new tab)
6.
Hyun J, et al. MicroRNA125b-mediated Hedgehog signaling influences liver regeneration by chorionic plate-derived mesenchymal stem cells. Sci. Rep. 2015;5:14135.
Not in our library10.1038/srep14135 (opens in a new tab)
7.
Mesenchymal stem cell-derived exosomes promote hepatic regeneration in drug-induced liver injury models · 2014
No notice
8.
Exosomes derived from human menstrual blood-derived stem cells alleviate fulminant hepatic failure · 2017
No notice
9.
Bottger R, et al. Lipid-based nanoparticle technologies for liver targeting. Adv. Drug Deliv. Rev. 2020;154-155:79-101.
Not in our library10.1016/j.addr.2020.06.017 (opens in a new tab)
10.
Lázaro-Ibáñez E, et al. Selection of fluorescent, bioluminescent, and radioactive tracers to accurately reflect extracellular vesicle biodistribution in vivo. ACS Nano. 2021;15:3212-3227.
Not in our library10.1021/acsnano.0c09873 (opens in a new tab)
11.
Membrane Radiolabelling of Exosomes for Comparative Biodistribution Analysis in Immunocompetent and Immunodeficient Mice - A Novel and Universal Approach · 2019
No notice
12.
Xiao Q, et al. The effects of protein corona on in vivo fate of nanocarriers. Adv. Drug Deliv. Rev. 2022;186:114356.
Not in our library10.1016/j.addr.2022.114356 (opens in a new tab)
13.
In vivo Protein Corona Formation: Characterizations, Effects on Engineered Nanoparticles’ Biobehaviors, and Applications · 2021
Not checked
14.
Heidarzadeh M, et al. Protein corona and exosomes: new challenges and prospects. Cell Commun. Signal. 2023;21:64.
Not in our library10.1186/s12964-023-01089-1 (opens in a new tab)
15.
Faruqu FN, et al. Defined serum-free three-dimensional culture of umbilical cord-derived mesenchymal stem cells yields exosomes that promote fibroblast proliferation and migration in vitro. FASEB J. 2021;35:e21206.
Not in our library10.1096/fj.202001768rr (opens in a new tab)
16.
How pure are your vesicles? · 2013
No notice
17.
Ramirez MI, et al. Technical challenges of working with extracellular vesicles. Nanoscale. 2018;10:881-906.
Not in our library10.1039/c7nr08360b (opens in a new tab)
18.
Tkach M, Théry C. Communication by extracellular vesicles: where we are and where we need to go. Cell. 2016;164:1226-1232.
Not in our library10.1016/j.cell.2016.01.043 (opens in a new tab)
19.
Jønson L, et al. Molecular composition of IMP1 ribonucleoprotein granules. Mol. Cell Proteom. 2007;6:798-811.
Not in our library10.1074/mcp.m600346-mcp200 (opens in a new tab)
20.
Schroeder HW, Cavacini L. Structure and function of immunoglobulins. J. Allergy Clin. Immunol. 2010;125:S41-S52.
Not in our library10.1016/j.jaci.2009.09.046 (opens in a new tab)
21.
Cougot N, Babajko S, Séraphin B. Cytoplasmic foci are sites of mRNA decay in human cells. J. Cell Biol. 2004;165:31-40.
Not in our library10.1083/jcb.200309008 (opens in a new tab)
22.
Chari A, et al. An assembly chaperone collaborates with the SMN complex to generate spliceosomal SnRNPs. Cell. 2008;135:497-509.
Not in our library10.1016/j.cell.2008.09.020 (opens in a new tab)
23.
Sunesson L, Hellman U, Larsson C. Protein kinase cepsilon binds peripherin and induces its aggregation, which is accompanied by apoptosis of neuroblastoma cells. J. Biol. Chem. 2008;283:16653-16664.
Not in our library10.1074/jbc.m710436200 (opens in a new tab)
24.
van Asbeck EC, et al. Mannose binding lectin plays a crucial role in innate immunity against yeast by enhanced complement activation and enhanced uptake of polymorphonuclear cells. BMC Microbiol. 2008;8:229.
Not in our library10.1186/1471-2180-8-229 (opens in a new tab)
25.
Takahashi K, et al. Relative roles of complement factor 3 and mannose-binding lectin in host defense against infection. Infect. Immun. 2005;73:8188-8193.
Not in our library10.1128/iai.73.12.8188-8193.2005 (opens in a new tab)
26.
The ambiguous role of mannose-binding lectin (MBL) in human immunity · 2021
Not checked
27.
Formation of a protein corona on the surface of extracellular vesicles in blood plasma · 2021
Not checked
28.
Gomes FG, et al. Synergy of human platelet-derived extracellular vesicles with secretome proteins promotes regenerative functions. Biomedicines. 2022;10:238.
Not in our library10.3390/biomedicines10020238 (opens in a new tab)
29.
A functional corona around extracellular vesicles enhances angiogenesis, skin regeneration and immunomodulation · 2022
No notice
30.
Churchman AH, et al. Serum albumin enhances the membrane activity of ZnO nanoparticles. Chem. Commun. (Camb.). 2013;49:4172-4174.
Not in our library10.1039/c3cc37871c (opens in a new tab)
31.
Rastogi L, Kora AJ, J A. Highly stable, protein capped gold nanoparticles as effective drug delivery vehicles for amino-glycosidic antibiotics. Mater. Sci. Eng. C. 2012;32:1571-1577.
Not in our library10.1016/j.msec.2012.04.044 (opens in a new tab)
32.
Zaloga J, et al. Development of a lauric acid/albumin hybrid iron oxide nanoparticle system with improved biocompatibility. Int J. Nanomed. 2014;9:4847-4866.
Not in our library10.2147/ijn.s68539 (opens in a new tab)
33.
Vauthier C, Lindner P, Cabane B. Configuration of bovine serum albumin adsorbed on polymer particles with grafted dextran corona. Colloids Surf. B. 2009;69:207-215.
Not in our library10.1016/j.colsurfb.2008.11.017 (opens in a new tab)
34.
Qi J, et al. Nanoparticles with dextran/chitosan shell and BSA/chitosan core–doxorubicin loading and delivery. Int. J. Pharm. 2010;393:176-184.
Not in our library10.1016/j.ijpharm.2010.03.063 (opens in a new tab)
35.
Li Z, et al. Insight into the preformed albumin corona on in vitro and in vivo performances of albumin-selective nanoparticles. Asian J. Pharm. Sci. 2019;14:52-62.
Not in our library10.1016/j.ajps.2018.07.002 (opens in a new tab)
36.
Nigam P, et al. Graphene quantum dots conjugated albumin nanoparticles for targeted drug delivery and imaging of pancreatic cancer. J. Mater. Chem. B. 2014;2:3190-3195.
Not in our library10.1039/c4tb00015c (opens in a new tab)
37.
Peng Q, et al. Preformed albumin corona, a protective coating for nanoparticles based drug delivery system. Biomaterials. 2013;34:8521-8530.
Not in our library10.1016/j.biomaterials.2013.07.102 (opens in a new tab)
38.
Takeuchi T, et al. Molecularly imprinted nanogels acquire stealth in situ by cloaking themselves with native dysopsonic proteins. Angew. Chem. Int. Ed. 2017;56:7088-7092.
Not in our library10.1002/anie.201700647 (opens in a new tab)
39.
Albrecht C, et al. Effect of chronic bile duct obstruction and LPS upon targeting of naproxen to the liver using naproxen–albumin conjugate. J. Drug Target. 1998;6:105-117.
Not in our library10.3109/10611869808997886 (opens in a new tab)
40.
Kamps JAAM, et al. Massive targeting of liposomes, surface-modified with anionized albumins, to hepatic endothelial cells. Proc. Natl Acad. Sci. USA. 1997;94:11681-11685.
Not in our library10.1073/pnas.94.21.11681 (opens in a new tab)
41.
Weisiger R, Gollan J, Ockner R. Receptor for albumin on the liver cell surface may mediate uptake of fatty acids and other albumin-bound substances. Science. 1981;211:1048-1051.
Not in our library10.1126/science.6258226 (opens in a new tab)
42.
Synergistic lipid compositions for albumin receptor mediated delivery of mRNA to the liver · 2020
No notice
43.
Liang X, et al. Extracellular vesicles engineered to bind albumin demonstrate extended circulation time and lymph node accumulation in mouse models. J. Extracell. Vesicles. 2022;11:e12248.
Not in our library10.1002/jev2.12248 (opens in a new tab)
44.
Lesniak A, et al. Serum heat inactivation affects protein corona composition and nanoparticle uptake. Biomaterials. 2010;31:9511-9518.
Not in our library10.1016/j.biomaterials.2010.09.049 (opens in a new tab)
45.
Simon J, et al. Protein denaturation caused by heat inactivation detrimentally affects biomolecular corona formation and cellular uptake. Nanoscale. 2018;10:21096-21105.
Not in our library10.1039/c8nr07424k (opens in a new tab)
46.
Faruqu FN, Xu L, Al-Jamal KT. Preparation of exosomes for siRNA delivery to cancer cells. J. Vis. Exp. 2018;5:10.3791/58814.
Not in our library10.3791/58814 (opens in a new tab)
47.
Schottler S, et al. Protein adsorption is required for stealth effect of poly(ethylene glycol)- and poly(phosphoester)-coated nanocarriers. Nat. Nanotechnol. 2016;11:372-377.
Not in our library10.1038/nnano.2015.330 (opens in a new tab)
48.
Design of experiment (DoE)-driven in vitro and in vivo uptake studies of exosomes for pancreatic cancer delivery enabled by copper-free click chemistry-based labelling · 2020
Not checked
49.
Formation and glomerular deposition of immune complexes in mice administered bovine serum albumin: Evaluation of dose, frequency, and biomarkers · 2019
Not checked
50.
Yoshikawa N, et al. Interaction of lipoplex with albumin enhances gene expression in hepatitis mice. Pharmaceutics. 2020;12:341.
Not in our library10.3390/pharmaceutics12040341 (opens in a new tab)
51.
Eddy AA, et al. Interstitial fibrosis in mice with overload proteinuria: deficiency of TIMP-1 is not protective. Kidney Int. 2000;58:618-628.
Not in our library10.1046/j.1523-1755.2000.00208.x (opens in a new tab)
52.
Wheeler DS, et al. The immunomodulatory effects of albumin in vitro and in vivo. Adv. Pharmacol. Sci. 2011;2011:691928.
Not in our library10.1155/2011/691928 (opens in a new tab)
53.
Aparicio-Vergara M, et al. Isolation of Kupffer cells and hepatocytes from a single mouse liver. Methods Mol. Biol. 2017;1639:161-171.
Not in our library10.1007/978-1-4939-7163-3_16 (opens in a new tab)
54.
Shi B, Abrams M, Sepp-Lorenzino L. Expression of asialoglycoprotein receptor 1 in human hepatocellular carcinoma. J. Histochem. Cytochem. 2013;61:901-909.
Not in our library10.1369/0022155413503662 (opens in a new tab)
55.
Braun JR, et al. The major subunit of the asialoglycoprotein receptor is expressed on the hepatocellular surface in mice lacking the minor receptor subunit. J. Biol. Chem. 1996;271:21160-21166.
Not in our library10.1074/jbc.271.35.21160 (opens in a new tab)
56.
Bon C, et al. Capacity limits of asialoglycoprotein receptor-mediated liver targeting. MAbs. 2017;9:1360-1369.
Not in our library10.1080/19420862.2017.1373924 (opens in a new tab)
57.
Movita D, et al. Inflammatory monocytes recruited to the liver within 24 hours after virus-induced inflammation resemble Kupffer cells but are functionally distinct. J. Virol. 2015;89:4809-4817.
Not in our library10.1128/jvi.03733-14 (opens in a new tab)
58.
Identification of a Kupffer cell subset capable of reverting the T cell dysfunction induced by hepatocellular priming · 2021
No notice
59.
Kinoshita M, et al. Characterization of two F4/80-positive Kupffer cell subsets by their function and phenotype in mice. J. Hepatol. 2010;53:903-910.
Not in our library10.1016/j.jhep.2010.04.037 (opens in a new tab)
60.
Connolly MK, et al. In hepatic fibrosis, liver sinusoidal endothelial cells acquire enhanced immunogenicity. J. Immunol. 2010;185:2200.
Not in our library10.4049/jimmunol.1000332 (opens in a new tab)
61.
Immunofluorescence identifies distinct subsets of endothelial cells in the human liver · 2017
No notice
62.
Hutchins NA, et al. Kupffer cells protect liver sinusoidal endothelial cells from Fas-dependent apoptosis in sepsis by down-regulating gp130. Am. J. Pathol. 2013;182:742-gp154.
Not in our library10.1016/j.ajpath.2012.11.023 (opens in a new tab)
63.
Mederacke I, et al. High-yield and high-purity isolation of hepatic stellate cells from normal and fibrotic mouse livers. Nat. Protoc. 2015;10:305-315.
Not in our library10.1038/nprot.2015.017 (opens in a new tab)
64.
Hwang I, et al. Retinol from hepatic stellate cells via STRA6 induces lipogenesis on hepatocytes during fibrosis. Cell Biosci. 2021;11:3.
Not in our library10.1186/s13578-020-00509-w (opens in a new tab)
65.
Ichikawa S, et al. Hepatic stellate cells function as regulatory bystanders. J. Immunol. 2011;186:5549-5555.
Not in our library10.4049/jimmunol.1003917 (opens in a new tab)

Cited by papers we hold 2

Questions about this paper

We email you if it is retracted, withdrawn, corrected or flagged.

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.